Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
Holders of 5% or more of ADIL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Adial Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 13G | 9.99%2.80M shares | New | Feb 18, 20261 filing | Feb 18, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Adial Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 18, 202611:06 AM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%2.80M shares | New | Dec 31, 2025 | SEC |
| Jun 23, 20256:03 AM ET | Intracoastal Capital, LLCand 2 others | 13G | 2.80%446.3K shares | NewBelow 5% | Jun 17, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Adial Pharmaceuticals, Inc. shares.
No Form 144 notices for Adial Pharmaceuticals, Inc. are on file.